Column Group LLC Ngm Biopharmaceuticals Inc Transaction History
Column Group LLC
- $160 Million
- Q1 2024
A detailed history of Column Group LLC transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Column Group LLC holds 18,136,735 shares of NGM stock, worth $0. This represents 17.97% of its overall portfolio holdings.
Number of Shares
18,136,735
Previous 18,136,735
-0.0%
Holding current value
$0
Previous $15.6 Million
84.89%
% of portfolio
17.97%
Previous 10.3%
Shares
3 transactions
Others Institutions Holding NGM
# of Institutions
78Shares Held
36.9MCall Options Held
1.1KPut Options Held
200-
Black Rock Inc. New York, NY3MShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$00.0% of portfolio
-
Step Stone Group LP La Jolla, CA1.57MShares$00.6% of portfolio
-
Ponoi Ii Management, LLC San Francisco, CA1.3MShares$044.41% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.3MShares$023.2% of portfolio
About NGM BIOPHARMACEUTICALS INC
- Ticker NGM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,365,904
- Description
- NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...